|
Product class:
|
Authorized package
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Package code:
|
1809097
|
|
Name of medicinal product:
|
Mirataz
|
|
Active substances:
|
|
|
ATC code:
|
QN06AX11
|
|
Dosage form:
|
transdermal ointment
|
|
Route of administration:
|
transdermal use
|
|
Strengh:
|
20mg 1g
|
|
Amount in package:
|
5g 1TK
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Class of active substance:
|
|
|
Additional information:
|
|
|
Indication:
|
For bodyweight gain in cats experiencing poor appetite and weight loss resulting from chronic medical
conditions (see section 5.1).
|
|
Safety features:
|
No
|
|
Summary of product characteristics (SPC):
|
|
|
Package information leaflet (PIL):
|
EST
|
|
Labelling:
|
|
|
Withdrawal time:
|
|
|
Species:
|
kass
|
|
Last imported to Estonia:
|
November 14, 2023
|
|
Marketing authorization holder:
|
Dechra Regulatory B.V.
|
|
Marketing authorization number:
|
EU/2/19/247
|
|
Marketing authorization issued on:
|
December 10, 2019
|
|
Marketing authorization expires on:
|
December 12, 2024
|
|
Marketing authorization procedure type:
|
Centralised
|
Entry/Changing date:
July 9, 2020
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere